| Medical and Health Sciences | 2021-2025 | 51 | ES 2 | 99.99 |
| Epidemiology | Lifetime | 511 | ES 10 | 99.36 |
| Hepatology | Lifetime | 275 | ES 13 | 97.82 |
| Infectious Diseases | Lifetime | 691 | ES 16 | 97.02 |
| Epidemiology | 2021-2025 | 7 | ES 1 | 99.96 |
| Health | 2021-2025 | 31 | ES 1 | 99.23 |
| Hepatology | 2021-2025 | 24 | ES 2 | 99.41 |
| Infectious Diseases | 2021-2025 | 103 | ES 3 | 98.34 |
| General Health Professions | 2021-2025 | 412 | ES 7 | 96.76 |
| Liver Disease Diagnosis and Treatment | Lifetime | 396 | ES 18 | 99.43 |
| Hepatitis C virus research | Lifetime | 273 | ES 9 | 99.19 |
| Hepatitis B Virus Studies | Lifetime | 310 | ES 8 | 99.10 |
| Vaccine Coverage and Hesitancy | Lifetime | 300 | ES 1 | 97.82 |
| HIV, Drug Use, Sexual Risk | Lifetime | 268 | ES 2 | 98.40 |
| Liver Disease and Transplantation | Lifetime | 652 | ES 33 | 98.39 |
| Diet, Metabolism, and Disease | Lifetime | 428 | ES 15 | 97.88 |
| HIV/AIDS Research and Interventions | Lifetime | 658 | ES 9 | 98.48 |
| Alcohol Consumption and Health Effects | Lifetime | 465 | ES 13 | 96.79 |
| Food Security and Health in Diverse Populations | Lifetime | 540 | ES 1 | 96.07 |
| HIV-related health complications and treatments | Lifetime | 537 | ES 24 | 96.06 |
| HIV/AIDS Impact and Responses | Lifetime | 253 | ES 1 | 94.98 |
| Misinformation and Its Impacts | Lifetime | 766 | ES 17 | 90.56 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 12 | ES 1 | 99.93 |
| Hepatitis C virus research | 2021-2025 | 10 | ES 2 | 99.75 |
| Liver Disease and Transplantation | 2021-2025 | 17 | ES 1 | 99.72 |
| HIV-related health complications and treatments | 2021-2025 | 6 | ES 1 | 98.93 |
| Hepatitis B Virus Studies | 2021-2025 | 16 | ES 2 | 99.54 |
| Alcohol Consumption and Health Effects | 2021-2025 | 8 | ES 2 | 99.29 |
| HIV/AIDS Research and Interventions | 2021-2025 | 28 | ES 1 | 99.32 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 28 | ES 1 | 99.10 |
| Diet, Metabolism, and Disease | 2021-2025 | 15 | ES 2 | 99.66 |
| Diet and metabolism studies | 2021-2025 | 90 | ES 8 | 98.73 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 56 | ES 1 | 98.51 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 821 | ES 9 | 96.88 |
| Food Security and Health in Diverse Populations | 2021-2025 | 159 | ES 1 | 95.14 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 340 | ES 5 | 93.56 |
| COVID-19 epidemiological studies | 2021-2025 | 884 | ES 16 | 90.94 |
| Chronic Disease Management Strategies | 2021-2025 | 665 | ES 21 | 87.05 |
| Misinformation and Its Impacts | 2021-2025 | 606 | ES 24 | 86.07 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 622 | ES 22 | 82.52 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 632 | ES 35 | 71.35 |
| HIV/AIDS Impact and Responses | 2021-2025 | 396 | ES 2 | 65.48 |
| Healthcare Systems and Practices | 2021-2025 | 957 | ES 4 | 63.15 |
